Heart drug dronedarone tested to stop AFib recurrence after ablation

NCT ID NCT04704050

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 33 times

Summary

This study looked at whether the drug dronedarone can prevent atrial fibrillation (AFib) from coming back after a heart ablation procedure. About 22 adults with AFib were randomly assigned to take either dronedarone or a placebo after their ablation. The goal was to see if dronedarone reduces AFib recurrence and slows scarring in the heart's upper chambers. The trial was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Tulane University School of Medicine

    New Orleans, Louisiana, 70112, United States

  • University of Colorado Health Memorial

    Colorado Springs, Colorado, 80909, United States

Conditions

Explore the condition pages connected to this study.